Healthcare / Health Information ServicesTaipei Exchange
$19.10
+0.15 (+0.79%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 20%
FCF escenarios
weak_data · normalized FCF $-12.1M · quality 55.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
29/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$611M
P/E
79.6x
↑EV/EBITDA
19.1x
↑ROE
2.4%
↑Gross Margin
68.9%
↑Debt/Equity
0.21
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-13.0%
FCF CAGR
—
FCF margin
-29.8%
FCF / Net income
-9.66x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $253.1M · net income $7.8M · FCF $-75.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $253.1M | $253.1M | $281.0M | $206.1M | $383.9M |
| Net Income | $7.8M | $7.8M | $2.1M | $-14.0M | $4.0M |
| EBITDA | $28.6M | $28.6M | $23.1M | $3.8M | $22.7M |
| EPS | — | — | 0.07 | -0.44 | 0.13 |
| Gross Margin | 68.9% | 68.9% | 63.4% | 75.2% | 48.0% |
| Operating Margin | 3.8% | 3.8% | 1.2% | -7.0% | 1.5% |
| Net Margin | 3.1% | 3.1% | 0.8% | -6.8% | 1.0% |
| Balance Sheet | |||||
| Debt/Equity | 0.21 | 0.21 | 0.27 | 0.41 | 0.27 |
| Current Ratio | 1.86 | 1.86 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-75.3M | $-75.3M | $118.7M | $-12.1M | $10.2M |
| Returns | |||||
| ROE | 2.4% | 2.4% | 0.7% | -4.6% | 1.3% |
| Valuation | |||||
| P/E | 79.58 | 79.58 | 338.57 | — | 150.77 |
| EV/EBITDA | 19.12 | 19.12 | 26.84 | 203.33 | 25.20 |
| P/B | 1.92 | 1.92 | 2.42 | 2.58 | 1.96 |
| Growth & Yield | |||||
| Revenue Growth | -9.9% | -9.9% | 36.3% | -46.3% | — |
| EPS Growth | — | — | 115.9% | -438.5% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-14.7%
Start / end P/E
n/dx → n/dx
EPS bridge
0.07 → n/d
Residual
-14.7%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.